Profil
Nick DeLong is the founder of Evolved Capital, Inc. He previously worked as the Head of Business Development at Tris Pharma, Inc. and as the Vice President of Corporate Development at iBio, Inc. He holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Rutgers University- Newark.
Anciens postes connus de Nick DeLong
| Sociétés | Poste | Fin |
|---|---|---|
| IBIO, INC. | Corporate Officer/Principal | 01/06/2024 |
Evolved Capital, Inc.
Evolved Capital, Inc. Packaged SoftwareTechnology Services Develops web-based tool | Fondateur | - |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Corporate Officer/Principal | - |
Formation de Nick DeLong
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iBio, Inc.
iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Health Technology |
Rutgers University- Newark
Rutgers University- Newark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evolved Capital, Inc.
Evolved Capital, Inc. Packaged SoftwareTechnology Services Develops web-based tool | Technology Services |
















